Sign In
Buy QTRX
$3.22
-0.270 (-7.74%)
At Close: Jun 23, 2026
Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
07:04am, Wednesday, 28'th Jul 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its fi
Will Quanterix Corporation (QTRX) Report Negative Q2 Earnings? What You Should Know
04:05pm, Tuesday, 27'th Jul 2021
Quanterix Corporation (QTRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quanterix Appoints Michael Doyle as Chief Financial Officer
04:08pm, Monday, 28'th Jun 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Si
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Exec
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2021 Results - Earnings Call Transcript
01:55pm, Sunday, 09'th May 2021
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2021 Results - Earnings Call Transcript
Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer's Disease
03:29pm, Thursday, 22'nd Apr 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced a webinar with leading indus
Quanterix Announces Appointment of Interim Chief Financial Officer
07:10am, Wednesday, 21'st Apr 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Simoa® technology
Olink Holding Pursues $300 Million U.S. IPO Effort
03:42pm, Monday, 22'nd Mar 2021
Olink Holding AB has filed to raise $300 million in a U.S. IPO.
Quanterix Shares Have Quadrupled Since IPO in Late 2017
04:12pm, Thursday, 04'th Mar 2021
Since going public just over three years ago, Quanterix Corp. (NASDAQ:QTRX) shares have quadrupled to about $63. Recently, the Billerica, Massachusetts-based diagnostics company closed another public
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q4 2020 Results - Earnings Call Transcript
11:25pm, Tuesday, 02'nd Mar 2021
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q4 2020 Results - Earnings Call Transcript
Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates
06:10pm, Tuesday, 02'nd Mar 2021
Quanterix Corporation (QTRX) delivered earnings and revenue surprises of -3.33% and 3.09%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief Executi
Quanterix Announces Simoa® Joint Laboratory with WuXi AppTec
02:08pm, Friday, 12'th Feb 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into an agre
